Women and lung cancer: does oestrogen play a role?
- PMID: 11905727
- DOI: 10.1016/S1470-2045(01)00457-0
Women and lung cancer: does oestrogen play a role?
Abstract
Smoking-related disease remains a major public-health problem. Large numbers of women continue to smoke, and new smokers are almost as likely to be female as male. Lung cancer is still a largely incurable disease; annual lung-cancer mortality in women exceeds that of breast cancer, and lung cancer now accounts for 12% of all new female cancer cases. The results of several studies suggest that women are more susceptible than men to lung cancer and to conditions that predispose to this cancer, such as chronic obstructive pulmonary disease. There is still much controversy about whether there is an increased lung-cancer risk in women across all populations. Many epidemiological studies have been negative or equivocal when comparing male and female lung-cancer risk. This article is not intended to be a comprehensive review of all epidemiological studies, or of all possible lung-cancer risk factors. Lung-cancer incidence and risk in women are discussed, and evidence for possible mechanisms of increased female risk are presented, including the role of oestrogen in the development of lung cancer.
Similar articles
-
The carcinogenic and toxic effects of tobacco smoke: are women particularly susceptible?J Gend Specif Med. 1999 Nov-Dec;2(6):45-51. J Gend Specif Med. 1999. PMID: 11279871 Review.
-
Sex and gender differences in lung cancer.J Gend Specif Med. 2003;6(1):37-48. J Gend Specif Med. 2003. PMID: 12661176 Review.
-
Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.Cancer Epidemiol Biomarkers Prev. 1994 Jun;3(4):289-98. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8061576
-
[Epidemiological novelties in lung cancer].Rev Mal Respir. 2011 Oct;28(8):1048-58. doi: 10.1016/j.rmr.2010.12.015. Epub 2011 Nov 1. Rev Mal Respir. 2011. PMID: 22099410 Review. French.
-
Smoking and cancer risk in Korean men and women.Cancer Causes Control. 2004 May;15(4):341-8. doi: 10.1023/B:CACO.0000027481.48153.97. Cancer Causes Control. 2004. PMID: 15141135
Cited by
-
Gene regulatory networks reveal sex difference in lung adenocarcinoma.Biol Sex Differ. 2024 Aug 6;15(1):62. doi: 10.1186/s13293-024-00634-y. Biol Sex Differ. 2024. PMID: 39107837 Free PMC article.
-
Gene regulatory Networks Reveal Sex Difference in Lung Adenocarcinoma.bioRxiv [Preprint]. 2023 Sep 24:2023.09.22.559001. doi: 10.1101/2023.09.22.559001. bioRxiv. 2023. Update in: Biol Sex Differ. 2024 Aug 6;15(1):62. doi: 10.1186/s13293-024-00634-y PMID: 37790409 Free PMC article. Updated. Preprint.
-
ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy.Front Oncol. 2023 Apr 27;13:1158104. doi: 10.3389/fonc.2023.1158104. eCollection 2023. Front Oncol. 2023. PMID: 37188197 Free PMC article.
-
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial.BMC Med. 2022 Dec 30;20(1):493. doi: 10.1186/s12916-022-02696-4. BMC Med. 2022. PMID: 36581917 Free PMC article. Clinical Trial.
-
Role of estrogen receptors in health and disease.Front Endocrinol (Lausanne). 2022 Aug 18;13:839005. doi: 10.3389/fendo.2022.839005. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36060947 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
